Yehuda Z Cohen

12PUBLICATIONS
66CO-AUTHORS
Innate immunityEpidemiological modellingGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 20, 2023
First-in-human study with SAR445088: A novel selective classical complement pathway inhibitor.

Timothy Chow, Pirouz Shamszad, Christopher Vinnard

|Apr 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud

|Jan 14, 2021
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.

Marcos V P Gondim, Scott Sherrill-Mix, Frederic Bibollet-Ruche

|Dec 10, 2020
Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates.

Julio C C Lorenzi, Pilar Mendoza, Yehuda Z Cohen

|Aug 26, 2020
Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.

Pablo K Valente, Yumeng Wu, Yehuda Z Cohen

|Aug 09, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.

Yehuda Z Cohen, Allison L Butler, Katrina Millard

Pageof 2

Frequent Collaborators

4 joint publications

Stephen R Walsh

3 joint publications

Lars G Hemkens

3 joint publications

Thomas Benfield

3 joint publications

Sherief Abd-Elsalam